Kevin Broadbelt

Kevin Broadbelt is an accomplished leader in biotechnology and lab operations, currently serving as the Director of Lab Operations at Thermo Fisher Scientific Innovation Lab since August 2022. Previously, Kevin held roles as a Sr. Product Specialist and Global Applications Scientist focused on biopharma and strategic marketing. An academic background includes tenure as an Associate Teaching Professor at Northeastern University and a Program Director for Biotechnology and Bioinformatics Master's Programs, alongside significant contributions as a Research Scientist at Harvard Medical School. Kevin's research experience spans neuropathology, particularly in Sudden Infant Death Syndrome, and developmental neuroscience, earned through a Ph.D. in Neuroscience from The Graduate Center, City University of New York.